Clinical Trials Directory

Trials / Completed

CompletedNCT05371210

An End-to-end System for Assessment and Intervention of Frailty

SAIF: An End-to-end System for Assessment and Intervention of Frailty

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
105 (actual)
Sponsor
Tan Tock Seng Hospital · Academic / Other
Sex
All
Age
60 Years – 90 Years
Healthy volunteers
Not accepted

Summary

The study aims to evaluate the feasibility and effectiveness of using SAIF (an end-to-end System for Assessment and Intervention of Frailty) to reduce the risk and delay the progress of physical frailty.

Detailed description

SAIF is a personalised, community-based system for both assessment and intervention of frailty. It comprises of 8 modules categorised into 1. Interface: virtual nurse and caregiver gateway 2. Assessment: computerised screening using Fried Frailty Phenotype (FFP) and FRAIL instruments, Gamified Walking While Talking to assess frailty status and predictive analytics to predict participant's frailty risk 3. Intervention: Physical exercise kiosks (Cycling and Taichi) incorporated with games, polypharmacy management and nutrition recommendation A total of 105 eligible community-dwelling older adults were recruited and randomised either to control arm or intervention arm using a single-consent Zelen's design. Allocation concealment was achieved using permutated block randomisation; both research assistant and participant were blinded to randomisation list during enrolment. All participants completed baseline assessment and subsequent follow-up assessments (2-month, 4-month and 7-month). Additionally, participants in the intervention arm began SAIF interaction for a period of 4 months upon completion of their baseline assessment.

Conditions

Interventions

TypeNameDescription
OTHERSAIFParticipants interacted with SAIF system at least 2-3 times per week; each session took up to 20 minutes.

Timeline

Start date
2021-03-15
Primary completion
2022-06-16
Completion
2022-06-16
First posted
2022-05-12
Last updated
2025-12-23

Locations

1 site across 1 country: Singapore

Source: ClinicalTrials.gov record NCT05371210. Inclusion in this directory is not an endorsement.